Literature DB >> 8314618

Cutaneous signs (Raynaud's phenomenon, sclerodactylia, and edema of the hands) and hand-arm vibration exposure.

C Nagata1, H Yoshida, S M Mirbod, Y Komura, S Fujita, R Inaba, H Iwata, M Maeda, Y Shikano, Y Ichiki.   

Abstract

Dermatological tests and examinations of the hand(s) were carried out in vibration-exposed and unexposed males. The subjects were 179 chain-saw workers in private forestry companies and 205 local inhabitants who had never used vibrating tools. The prevalences of Raynaud's phenomenon (RP), sclerodactylia, and edema of the hands were estimated in both groups, and associations between these cutaneous signs and vibration exposure were evaluated. The prevalences of RP and edema in the exposed group were 9.5% and 1.7%, respectively, and in the unexposed group, 2.9% and 1.5%, respectively. Sclerodactylia was seen in 31.8% of the chain-saw workers but in only 6.4% of the unexposed individuals. In statistical analyses based on unconditional logistic regression models with adjustment for age, RP was associated with long-term (> or = 20 years) vibration exposure [odds ratio (OR) = 7.06; 95% confidence interval (CI) = 2.51-19.87]. Sclerodactylia was associated with both short- and long-term vibration exposure (OR = 6.54, CI = 3.30-13.36; OR = 7.05; CI = 3.41-14.60, respectively). There were significant dose-response relationships between RP and duration of exposure and between sclerodactylia and duration of exposure. Results of function tests indicated a longer recovery time and a higher vibration threshold for the workers with RP. The presence of sclerodactylia, however, did not have any significant influence on function test results. It is possible to conclude that not only RP but also sclerodactylia could be induced by vibration exposure. However, most cases of sclerodactylia were not so serious as to involve disturbances of peripheral circulatory and nerve function.

Entities:  

Mesh:

Year:  1993        PMID: 8314618     DOI: 10.1007/bf00517705

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  22 in total

1.  Systemic scleroderma, A clinical study of 727 cases.

Authors:  D L TUFFANELLI; R K WINKELMANN
Journal:  Arch Dermatol       Date:  1961-09

2.  Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations.

Authors:  L D ERASMUS
Journal:  S Afr J Lab Clin Med       Date:  1957-09

Review 3.  Clinical aspects of the hand-arm vibration syndrome. A review.

Authors:  I Pyykkö
Journal:  Scand J Work Environ Health       Date:  1986-10       Impact factor: 5.024

4.  Vibration white finger and digital systolic pressure during cooling.

Authors:  L Ekenvall; L E Lindblad
Journal:  Br J Ind Med       Date:  1986-04

5.  Raynaud's phenomenon in forestry workers in Quebec.

Authors:  G Thériault; L De Guire; S Gingras; G Laroche
Journal:  Can Med Assoc J       Date:  1982-06-15       Impact factor: 8.262

Review 6.  Physiological methods used in Japan for the diagnosis of suspected hand-arm vibration syndrome.

Authors:  T Matoba; T Sakurai
Journal:  Scand J Work Environ Health       Date:  1987-08       Impact factor: 5.024

Review 7.  A study on the vibration-dose limit for Japanese workers exposed to hand-arm vibration.

Authors:  S M Mirbod; R Inaba; H Iwata
Journal:  Ind Health       Date:  1992       Impact factor: 2.179

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979.

Authors:  C J Michet; C H McKenna; L R Elveback; R A Kaslow; L T Kurland
Journal:  Mayo Clin Proc       Date:  1985-02       Impact factor: 7.616

10.  Vibration elicited vasoconstrictor reflex in Raynaud's phenomena.

Authors:  N Olsen; O U Petring
Journal:  Br J Ind Med       Date:  1988-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.